. home.aspx



Outsourcing biology CRO and preclinical research studies during COVID19 pandemic

May 15, 2020 / PR Newswire

While the COVID-19 pandemic continues to evolve, many Cancer Research Institutions and Pharma/Biotech companies are considering how to restart the biomedical research and drug development programs. This may include thinking through meeting the timeline, risk of mitigation actions, and possible program reprioritizations as components of the strategy to return to normal operations. Our preclinical services allow scientists to discover new innovative therapies effective in serious diseases without known treatment. Science never stops. All of us at Altogen Labs are committed to help advancing biomedical research to improve human health. We developed an Instant Online Quote tool to advance research program planning and scheduling. Scientists can select experimental variables (such as strain, number of treatment and control groups, treatment frequency, route of test article administration, etc) and generate an instant quotation for the project. Efficacy and safety toxicology studies are...